Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–63.

Article  PubMed  PubMed Central  Google Scholar 

Caron C, Rutter M. Comorbidity in child psychopathology: concepts, issues and research strategies. J Child Psychol Psychiatry. 1991;32:1063–80.

Article  CAS  PubMed  Google Scholar 

Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry Allied Disciplines. 1999;40:57–87.

Article  CAS  Google Scholar 

Lilienfeld SO, Waldman ID, Israel AC. A critical examination of the use of the term and concept of comorbidity in psychopathology research. Clin Psychol Sci Pract. 1994;1:71–83.

Article  Google Scholar 

•• Wetterling T. Pathogenesis of multimorbidity—what is known? Z Gerontol Geriatr. 2021;54:590–6. Interesting article describing different putative mechanisms that might explain multimorbidity.

Article  PubMed  Google Scholar 

Font H, Roelandt J-L, Behal H, Geoffroy P-A, Pignon B, Amad A, et al. Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the ‘Mental Health in General Population’ (MHGP) survey. Soc Psychiatry Psychiatr Epidemiol. 2018;53:567–76.

Article  PubMed  Google Scholar 

Fan Z, Wu Y, Shen J, Ji T, Zhan R. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. J Psychiatr Res. 2013;47:1549–56.

Article  PubMed  Google Scholar 

• Kowal C, Peyre H, Amad A, Pelissolo A, Leboyer M, Schürhoff F, et al. Psychotic, mood, and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis. Psychosom Med. 2020;82:838–49. This systematic review and meta-analysis of the association between venous thromboembolism and psychiatric disorders revealed that psychotic disorders increased the risk of pulmonary embolism, deep veinous thrombosis and fatal issues.

Article  PubMed  Google Scholar 

•• Ali S, Santomauro D, Ferrari AJ, Charlson F. Excess mortality in severe mental disorders: a systematic review and meta-regression. J Psychiatr Res. 2022;149:97–105. The most recent estimation, based on meta-analytical data, of the excess mortality from cardiovascular and diabetes in subjects with schizophrenia.

Article  PubMed  Google Scholar 

Ali S, Santomauro D, Ferrari AJ, Charlson F. Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment. Epidemiol Psychiatr Sci. 2023;32:e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moran P, Stewart R, Brugha T, Bebbington P, Bhugra D, Jenkins R, et al. Personality disorder and cardiovascular disease: results from a national household survey. J Clin Psychiatry. 2007;68:69–74.

Article  PubMed  Google Scholar 

Quirk SE, El-Gabalawy R, Brennan SL, Bolton JM, Sareen J, Berk M, et al. Personality disorders and physical comorbidities in adults from the United States: data from the National Epidemiologic Survey on Alcohol and Related Conditions. Soc Psychiatry Psychiatr Epidemiol. 2015;50:807–20.

Article  PubMed  Google Scholar 

Mothi SS, Tandon N, Padmanabhan J, Mathew IT, Clementz B, Tamminga C, et al. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophr Res. 2015;165:103–7.

Article  PubMed  PubMed Central  Google Scholar 

• Suetani S, Honarparvar F, Siskind D, Hindley G, Veronese N, Vancampfort D, et al. Increased rates of respiratory disease in schizophrenia: a systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls. Schizophr Res. 2021;237:131–40. Recent meta-analysis of the association between schizophrenia and respiratory diseases (asthma, COPD, pneumonia).

Article  PubMed  Google Scholar 

Jaén-Moreno MJ, Rico-Villademoros F, Ruiz-Rull C, Laguna-Muñoz D, Del Pozo GI, Sarramea F. A systematic review on the association between schizophrenia and bipolar disorder with chronic obstructive pulmonary disease. COPD. 2023;20:31–43.

Article  PubMed  Google Scholar 

Mirabelli MC, Beavers SF, Chatterjee AB, Moorman JE. Age at asthma onset and subsequent asthma outcomes among adults with active asthma. Respir Med. 2013;107:1829–36.

Article  PubMed  PubMed Central  Google Scholar 

Pedersen MS, Benros ME, Agerbo E, Børglum AD, Mortensen PB. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res. 2012;138:58–62.

Article  PubMed  Google Scholar 

Wang WC, Lu ML, Chen VCH, Ng MH, Huang KY, Hsieh MH, et al. Asthma, corticosteroid use and schizophrenia: a nationwide population-based study in Taiwan. PLOS ONE. 2017;12:e0173063.

Article  PubMed  PubMed Central  Google Scholar 

Wu Q, Dalman C, Karlsson H, Lewis G, Osborn DPJ, Gardner R, et al. Childhood and parental asthma, future risk of bipolar disorder and schizophrenia spectrum disorders: a population-based cohort study. Schizophr Bull. 2019;45:360–8.

Article  PubMed  Google Scholar 

Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. AJP. 2014;171:1045–51.

Article  Google Scholar 

Broberg BV, Sommer IE, Benros ME, Glenthøj BY, Gasse C, Köhler-Forsberg O. Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – a Danish nationwide study. Schizophr Res. 2018;199:116–22.

Article  PubMed  Google Scholar 

Stevens JR. Schizophrenia and multiple sclerosis. Schizophr Bull. 1988;14:231–41.

Article  CAS  PubMed  Google Scholar 

Arneth BM. Multiple sclerosis and schizophrenia. Int J Mol Sci. 2017;18:1760.

Article  PubMed  PubMed Central  Google Scholar 

• Cao Y, Ji S, Chen Y, Zhang X, Ding G, Tang F. Association between autoimmune diseases of the nervous system and schizophrenia: a systematic review and meta-analysis of cohort studies. Compr Psychiatry. 2023;122:152370. Recent meta-analysis on the association between autoimmune nervous disorders (more notably multiple sclerosis) and schizophrenia (complements an older meta-analysis ref. 64, Cullen et al. focusing on non-neurological autoimmune disorders).

Article  PubMed  Google Scholar 

Meier U-C, Ramagopalan SV, Goldacre MJ, Goldacre R. Risk of schizophrenia and bipolar disorder in patients with multiple sclerosis: record-linkage studies. Front Psychiatry [Internet]. 2020 [cited 2023 Dec 21];11. Available from: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00662.

Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry. 2014;14:75.

Article  PubMed  PubMed Central  Google Scholar 

Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207–20.

Article  CAS  PubMed  Google Scholar 

Qin P, Xu H, Laursen TM, Vestergaard M, Mortensen PB. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ. 2005;331:23.

Article  PubMed  PubMed Central  Google Scholar 

Chang Y-T, Chen P-C, Tsai I-J, Sung F-C, Chin Z-N, Kuo H-T, et al. Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study. Epilepsia. 2011;52:2036–42.

Article  PubMed  Google Scholar 

Wotton CJ, Goldacre MJ. Coexistence of schizophrenia and epilepsy: record-linkage studies. Epilepsia. 2012;53:e71–4.

Article  PubMed  Google Scholar 

Clarke MC, Tanskanen A, Huttunen MO, Clancy M, Cotter DR, Cannon M. Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study. Biol Psychiat. 2012;71:836–9.

Article  PubMed  Google Scholar 

• Lindekilde N, Scheuer SH, Rutters F, Knudsen L, Lasgaard M, Rubin KH, et al. Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews. Diabetologia. 2022;65:440–56. The most recent and complete analysis of the association between T2DM and psychiatric disorders (including psychosis/schizophrenia).

Article  PubMed  Google Scholar 

Greenhalgh AM, Gonzalez-Blanco L, Garcia-Rizo C, Fernandez-Egea E, Miller B, Arroyo MB, et al. Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis. Schizophr Res. 2017;179:57–63.

Article  PubMed  Google Scholar 

Rajkumar AP, Horsdal HT, Wimberley T, Cohen D, Mors O, Børglum AD, et al. Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry. 2017;174:686–94.

Article  PubMed  Google Scholar 

•• Morera D, Miller BJ. Meta-analysis of a family history of diabetes in schizophrenia. Schizophr Res. 2024;264:90–4. This study demonstrates that patients with schizophrenia compared with controls have more than a double increase in odds of a family history of T2DM versus controls.

Article  CAS  PubMed  Google Scholar 

Afzal M, Siddiqi N, Ahmad B, Afsheen N, Aslam F, Ali A, et al. Prevalence of overweight and obesity in people with severe mental illness: systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021;12:769309.

Article  PubMed  Google Scholar 

Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339–47.

Article  PubMed  PubMed Central  Google Scholar 

Gurpegui M, Martínez-Ortega JM, Gutiérrez-Rojas L, Rivero J, Rojas C, Jurado D. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37:169–75.

Article  PubMed  Google Scholar 

Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand. 2015;132:97–108.